Laddar populära aktier...
Redeye provides a research update following the Q3 report published by Cinclus earlier today.
Redeye leaves a comment following Cinclus’ recent announcement that it has agreed on Paediatric Investigation Plan (PIP) with EMA.
Redeye leaves a short comment following Cinclus’ recent announcement that the manufacturing of the Investigational Medicinal Product (IMP), ...
Redeye initiates coverage of Cinclus Pharma, a Swedish biotech company offering a next-generation solution to the USD+5bn GERD treatment mar...